Patient access to 24/7 palliative care medicines is ‘insufficient’, finds House of Commons-commissioned report The report also suggested that there was a “postcode lottery” in integrated care board provision of palliative care and end-of-life services.…
Lead paediatric palliative care pharmacists should be part of local plans, says RPS In its updated palliative care policy, the Royal Pharmaceutical Society advised that families and medical colleagues would benefit from the medicines expertise of a specialist paediatric palliative care pharmacist.…
Prescribing guidance for older people with frailty is aimed to balance harms and benefits of medicines The guidance, published by the British Geriatrics Society, suggests that patients with hypertension and moderate frailty may benefit from a more lenient average systemic blood pressure target.…
Behavioural self-assessment tool can encourage medicines adherence The ‘Social, Psychological, Usage and Rational’ tool measures the medicines non-adherence risk of patients by analysing social, psychological, usage and rational drivers.…
Tips for effective lipid management consultations for secondary prevention of cardiovascular disease Practical advice for pharmacy teams on how to provide long-term support for patients, improve adherence and achieve target lipid-levels.…
Antibiotics for back pain — a viable treatment option or pathway to antimicrobial resistance? In 2013, research findings suggested that antibiotics could treat chronic back pain, but these claims were disputed in the scientific community. Now companies are offering this treatment privately. Here, we investigate the contentious world of back pain treatment.…
Boots launches support service for patients coming off weight-loss drugs The service will provide users of the Boots Online Doctor weight-loss service unlimited support for 12 months, alongside various resources and ways to seek advice.…
What will changes to the new medicine service mean for pharmacists and patients? With recent changes to its scope to include antidepressants, new payment structures and the use of subcontractors, The Pharmaceutical Journal examines how successful the new medicine service has been and how it should evolve to meet future demand.…
Bruton tyrosine kinase inhibitors and B-cell malignancies: a guide for pharmacists This learning article with interactive elements provides an overview of the available Bruton tyrosine kinase inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice.… Supported content
Polypharmacy programme could have saved NHS more than £1m, report finds The Health Innovation Network’s polypharmacy programme provided training and support to healthcare professionals to tackle overprescribing, as well as developing resources to improve communication with patients.…
